MedDataX Logo

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

NCT ID: NCT06171425

Last Updated: 2023-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-12-25

Study Completion Date

2024-02-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are very few studies in the literature examining the frailty levels of diffuse parenchymal lung disease (DPLD) patients and its effect on their functional status despite the high prevalance of frailty in patients with DPLD This observational study aims to learn about the relationship between frailty and functional capacity and balance in DPLD patients compared to healthy subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to evaluate the relationship between the level of frailty and exercise capacity, respiratory functions, diffusion capacity, balance level, postural changes, activities of daily living, peripheral muscle strength and quality of life parameters in DPLD patients. The second aim is to compare diffuse parenchymal lung patients and the healthy control group in terms of these parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diffuse Parenchymal Lung Disease Frailty Physical Inactivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DPAH group

patients with diffuse parenchymal lung diseases

No interventions assigned to this group

control group

aged matched healthy patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with Diffuse parenchymal lung according to the American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,
* Being between the ages of 30-65,
* Being literate,
* Being willing to participate in the research,
* Being clinically stable and having any accompanying comorbid conditions (such as hypertension, diabetes) under control,
* Not having any orthopedic, metabolic or neurological problems that may prevent evaluation of peripheral muscle strength, balance and exercise capacity.

Exclusion Criteria

* Having recently experienced syncope,
* Having a history of unstable cardiovascular disease,
* Having been hospitalized due to exacerbation in the last 3 months,
* Having received pulmonary rehabilitation in the last 12 months,
* Having a neurological disease,
* Being dependent and using a walking aid while performing the person's daily life activities,
* Having a pacemaker,
* Having a diagnosis of lung cancer
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aynur Demirel

PT, PhD, Assoc. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hacettepe University, Health Sciences Faculty

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

AYNUR DEMIREL, Assoc. Prof.

Role: CONTACT

Phone: +9053123051576

Email: [email protected]

Aynur Demirel

Role: CONTACT

Phone: 05545295057

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GO 23/18

Identifier Type: -

Identifier Source: org_study_id